Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Change in Accured Expenses came in at -$2.2 million in Q3 2025, down 778.06% year-over-year from $319000.0 in Q3 2024, and up 13.55% quarter-over-quarter from -$2.5 million in Q2 2025.
Analysis
Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Change in Accured Expenses for 6 consecutive years, with -$2.2 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Change in Accured Expenses fell 778.06% year-over-year to -$2.2 million in Q3 2025; TTM through Sep 2025 was -$4.1 million, a 1530.16% decrease from a year earlier, with the FY2024 full-year figure at $309000.0, up 137.09% from the prior year.
- Change in Accured Expenses was -$2.2 million for Q3 2025 at Vicarious Surgical, up from -$2.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.8 million in Q4 2021 and troughed at -$2.5 million in Q2 2025.
- A 5-year average of $27000.0 and a median of $287000.0 in 2025 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 10227.55% in 2021, down 5779.1% in 2021.
- Over 5 years, Change in Accured Expenses stood at $2.8 million in 2021, then plunged by 84.42% to $443000.0 in 2022, then slumped by 165.69% to -$291000.0 in 2023, then jumped by 192.78% to $270000.0 in 2024, then slumped by 901.11% to -$2.2 million in 2025.
- The last three Change in Accured Expenses figures came in at -$2.2 million (Q3 2025), -$2.5 million (Q2 2025), and $287000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -291,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | -1.98 Mn |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -552,974.00 |
| Mar 31, 2021 | 1.34 Mn |
| Dec 31, 2020 | 27,538.00 |